-
1
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
-
Hanauer S.B., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 359:2002;1541-1549
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
-
2
-
-
0023521441
-
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: A randomized study
-
Schroeder K.W., Tremaine W.J., Ilstrup D.M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med. 317:1987;1625-1629
-
(1987)
N Engl J Med
, vol.317
, pp. 1625-1629
-
-
Schroeder, K.W.1
Tremaine, W.J.2
Ilstrup, D.M.3
-
3
-
-
0029875942
-
Changes in extent of ulcerative colitis: A study on the course and prognostic factors
-
Langholz E., Munkholm P., Davidsen M., Nielsen O.H., Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 31:1996;260-266
-
(1996)
Scand J Gastroenterol
, vol.31
, pp. 260-266
-
-
Langholz, E.1
Munkholm, P.2
Davidsen, M.3
Nielsen, O.H.4
Binder, V.5
-
4
-
-
0033504205
-
Serologic testing for inflammatory bowel disease
-
Hoffenberg E.J., Fidanza S., Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr. 134:1999;447-452
-
(1999)
J Pediatr
, vol.134
, pp. 447-452
-
-
Hoffenberg, E.J.1
Fidanza, S.2
Sauaia, A.3
-
5
-
-
0036726184
-
Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens
-
Landers C.J., Cohavy O., Misra R., Yang H., Lin Y.C., Braun J., et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 123:2002;689-699
-
(2002)
Gastroenterology
, vol.123
, pp. 689-699
-
-
Landers, C.J.1
Cohavy, O.2
Misra, R.3
Yang, H.4
Lin, Y.C.5
Braun, J.6
-
6
-
-
0034887447
-
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease
-
Sandborn W.J., Loftus E.V., Colombel J.F., Fleming K.A., Seibold F., Homburger H.A., et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 7:2001;192-201
-
(2001)
Inflamm Bowel Dis
, vol.7
, pp. 192-201
-
-
Sandborn, W.J.1
Loftus, E.V.2
Colombel, J.F.3
Fleming, K.A.4
Seibold, F.5
Homburger, H.A.6
-
7
-
-
0036242774
-
The value of serologic markers in indeterminate colitis: A prospective follow-up study
-
Joossens S., Reinisch W., Vermeire S., Sendid B., Poulain D., Peeters M., et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 122:2002;1242-1247
-
(2002)
Gastroenterology
, vol.122
, pp. 1242-1247
-
-
Joossens, S.1
Reinisch, W.2
Vermeire, S.3
Sendid, B.4
Poulain, D.5
Peeters, M.6
-
8
-
-
0037372740
-
Diagnosing small bowel Crohn's disease with wireless capsule endoscopy
-
Fireman Z., Mahajna E., Broide E., Shapiro M., Fich L., Sternberg A., et al. Diagnosing small bowel Crohn's disease with wireless capsule endoscopy. Gut. 52:2003;390-392
-
(2003)
Gut
, vol.52
, pp. 390-392
-
-
Fireman, Z.1
Mahajna, E.2
Broide, E.3
Shapiro, M.4
Fich, L.5
Sternberg, A.6
-
9
-
-
0242668401
-
Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn's disease
-
Eliakim R., Fischer D., Suissa A., Yassin K., Kathz D., Guttman N., et al. Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn's disease. Eur J Gastroenterol Hepatol. 15:2003;363-367
-
(2003)
Eur J Gastroenterol Hepatol
, vol.15
, pp. 363-367
-
-
Eliakim, R.1
Fischer, D.2
Suissa, A.3
Yassin, K.4
Kathz, D.5
Guttman, N.6
-
10
-
-
0002243814
-
Medical therapy for ulcerative colitis
-
J.B. Kirsner. Philadelphia: WB Saunders
-
Hanauer S.B. Medical therapy for ulcerative colitis. Kirsner J.B. Inflammatory bowel disease. 5th edition:2000;529-556 WB Saunders, Philadelphia
-
(2000)
Inflammatory Bowel Disease 5th Edition
, pp. 529-556
-
-
Hanauer, S.B.1
-
11
-
-
0034936972
-
Outcome of cytomegalovirus infections in patients with inflammatory bowel disease
-
Papadakis K.A., Tung J.K., Binder S.W., Kam L.Y., Abreu M.T., Targan S.R., et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol. 96:2001;2137-2142
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2137-2142
-
-
Papadakis, K.A.1
Tung, J.K.2
Binder, S.W.3
Kam, L.Y.4
Abreu, M.T.5
Targan, S.R.6
-
12
-
-
0033118686
-
Cytomegalovirus in patients with inflammatory bowel disease
-
Vega R., Bertran X., Menacho M., Domenech E., Moreno de Vega V., Hombrados M., et al. Cytomegalovirus in patients with inflammatory bowel disease. Am J Gastroenterol. 94:1999;1053-1056
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 1053-1056
-
-
Vega, R.1
Bertran, X.2
Menacho, M.3
Domenech, E.4
Moreno De Vega, V.5
Hombrados, M.6
-
13
-
-
0035070678
-
Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naïve patient
-
Pfau P., Kochman M.L., Furth E.E., Lichtenstein G.R. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naïve patient. Am J Gastroenterol. 96:2001;895-899
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 895-899
-
-
Pfau, P.1
Kochman, M.L.2
Furth, E.E.3
Lichtenstein, G.R.4
-
15
-
-
0035074282
-
Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis
-
Cottone M., Pietrosi G., Martorana G., Casa A., Pecoraro G., Oliva L., et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 96:2001;773-775
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 773-775
-
-
Cottone, M.1
Pietrosi, G.2
Martorana, G.3
Casa, A.4
Pecoraro, G.5
Oliva, L.6
-
16
-
-
0033910277
-
Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis
-
Farrell R.J., LaMont J.T. Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis. Curr Top Microbiol Immunol. 250:2000;109-125
-
(2000)
Curr Top Microbiol Immunol
, vol.250
, pp. 109-125
-
-
Farrell, R.J.1
Lamont, J.T.2
-
17
-
-
0019484831
-
Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease
-
Trnka Y.M., LaMont J.T. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology. 80:1981;693-696
-
(1981)
Gastroenterology
, vol.80
, pp. 693-696
-
-
Trnka, Y.M.1
Lamont, J.T.2
-
18
-
-
0020601653
-
Clostridium difficile and inflammatory bowel disease
-
Greenfield C., Aguilar Ramirez J.R., Pounder R.E., Williams T., Danvers M., Marper S.R. Clostridium difficile and inflammatory bowel disease. Gut. 24:1983;713-717
-
(1983)
Gut
, vol.24
, pp. 713-717
-
-
Greenfield, C.1
Aguilar Ramirez, J.R.2
Pounder, R.E.3
Williams, T.4
Danvers, M.5
Marper, S.R.6
-
19
-
-
0018882007
-
Clostridium difficile associated diarrhea: A role in inflammatory bowel disease?
-
Bolton R.P., Sherriff R.J., Read A.E. Clostridium difficile associated diarrhea: a role in inflammatory bowel disease? Lancet. 1:1980;383-384
-
(1980)
Lancet
, vol.1
, pp. 383-384
-
-
Bolton, R.P.1
Sherriff, R.J.2
Read, A.E.3
-
20
-
-
0020075838
-
Clostridium difficile toxin in acute diarrhea complicating inflammatory bowel disease
-
Keighley M.R.B., Youngs D., Johnson M., Allan R.N., Burdon D.W. Clostridium difficile toxin in acute diarrhea complicating inflammatory bowel disease. Gut. 23:1982;410-414
-
(1982)
Gut
, vol.23
, pp. 410-414
-
-
Keighley, M.R.B.1
Youngs, D.2
Johnson, M.3
Allan, R.N.4
Burdon, D.W.5
-
21
-
-
0020698575
-
Occurrence of Clostridium difficile toxin in inflammatory bowel disease
-
Rolny P., Jarnerot G., Mollby R. Occurrence of Clostridium difficile toxin in inflammatory bowel disease. Scand J Gastroenterol. 18:1983;61-64
-
(1983)
Scand J Gastroenterol
, vol.18
, pp. 61-64
-
-
Rolny, P.1
Jarnerot, G.2
Mollby, R.3
-
22
-
-
2942580368
-
The diagnostic yield of stool studies during relapses of inflammatory bowel disease
-
[abstract]
-
Meyer A.M., Ramzan N.N., Loftus E.V., et al. The diagnostic yield of stool studies during relapses of inflammatory bowel disease. [abstract] Gastroenterology. 122:(4 Suppl 1):2002;A-219
-
(2002)
Gastroenterology
, vol.122
, Issue.4 SUPPL. 1
, pp. 219
-
-
Meyer, A.M.1
Ramzan, N.N.2
Loftus, E.V.3
-
23
-
-
0034827897
-
Failure of single-toxin assays to detect Clostridium difficile infection in pediatric inflammatory bowel disease
-
Markowitz J.E., Brown K.A., Mamula P., Drott H.R., Piccoli D.A., Baldassano R.N. Failure of single-toxin assays to detect Clostridium difficile infection in pediatric inflammatory bowel disease. Am J Gastroenterol. 96:2001;2688-2690
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2688-2690
-
-
Markowitz, J.E.1
Brown, K.A.2
Mamula, P.3
Drott, H.R.4
Piccoli, D.A.5
Baldassano, R.N.6
-
24
-
-
0031742216
-
Clostridium difficile-associated diarrhea and colitis: Clinical manifestations, diagnosis, and treatment
-
Cleary R.K. Clostridium difficile-associated diarrhea and colitis: clinical manifestations, diagnosis, and treatment. Dis Colon Rectum. 41:1998;1435-1449
-
(1998)
Dis Colon Rectum
, vol.41
, pp. 1435-1449
-
-
Cleary, R.K.1
-
25
-
-
0031050776
-
Ulcerative colitis practice guidelines in adults
-
Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol. 92:1997;204-211
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 204-211
-
-
Kornbluth, A.1
Sachar, D.B.2
-
26
-
-
6844237647
-
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis
-
Green J.R.B., Lobo A.J., Holdsworth C.D., Leicester R.J., Gibson J.A., Kerr G.D., et al. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. Gastroenterology. 114:1998;15-22
-
(1998)
Gastroenterology
, vol.114
, pp. 15-22
-
-
Green, J.R.B.1
Lobo, A.J.2
Holdsworth, C.D.3
Leicester, R.J.4
Gibson, J.A.5
Kerr, G.D.6
-
27
-
-
0001845158
-
The pharmacology of anti-inflammatory drugs in inflammatory bowel disease
-
J.B. Kirsner. Philadelphia: WB Saunders
-
Hanauer S.B., Kane S. The pharmacology of anti-inflammatory drugs in inflammatory bowel disease. Kirsner J.B. Inflammatory bowel disease. 5th edition:2000;510-528 WB Saunders, Philadelphia
-
(2000)
Inflammatory Bowel Disease 5th Edition
, pp. 510-528
-
-
Hanauer, S.B.1
Kane, S.2
-
28
-
-
0034093057
-
Genotypic analysis of thiopurine s-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
-
Colombel J.F., Ferrari N., Debuysere H., Marteau P., Gendre J.P., Bonaz B., et al. Genotypic analysis of thiopurine s-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology. 118:2000;1025-1030
-
(2000)
Gastroenterology
, vol.118
, pp. 1025-1030
-
-
Colombel, J.F.1
Ferrari, N.2
Debuysere, H.3
Marteau, P.4
Gendre, J.P.5
Bonaz, B.6
-
29
-
-
0038054562
-
Ten common errors in the management of inflammatory bowel disease
-
Sachar D.B. Ten common errors in the management of inflammatory bowel disease. Inflamm Bowel Dis. 9:2003;205-209
-
(2003)
Inflamm Bowel Dis
, vol.9
, pp. 205-209
-
-
Sachar, D.B.1
-
30
-
-
0034067784
-
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
-
Dubinsky M.C., Lamothe S., Yang H.Y., Targan S.R., Sinnett D., Theoret Y., et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 118:2000;705-713
-
(2000)
Gastroenterology
, vol.118
, pp. 705-713
-
-
Dubinsky, M.C.1
Lamothe, S.2
Yang, H.Y.3
Targan, S.R.4
Sinnett, D.5
Theoret, Y.6
-
31
-
-
0035037706
-
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease
-
Cuffari C., Hunt S., Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimize azathioprine therapy in patients with inflammatory bowel disease. Gut. 48:2001;642-646
-
(2001)
Gut
, vol.48
, pp. 642-646
-
-
Cuffari, C.1
Hunt, S.2
Bayless, T.3
-
32
-
-
0035037703
-
Rational dosing of azathioprine and 6-mercaptopurine
-
Sandborn W.J. Rational dosing of azathioprine and 6-mercaptopurine. Gut. 48:2001;591-592
-
(2001)
Gut
, vol.48
, pp. 591-592
-
-
Sandborn, W.J.1
-
33
-
-
2942515666
-
Red cell mean corpuscular volume correlates with 6 thioguanine nucleotide levels during azathioprine or 6-MP therapy for Crohn's disease
-
[abstract]
-
Jobson B., Garza A., Sninsky C.A. Red cell mean corpuscular volume correlates with 6 thioguanine nucleotide levels during azathioprine or 6-MP therapy for Crohn's disease. [abstract] Gastroenterology. 120:(5 Suppl 1):2001;A4
-
(2001)
Gastroenterology
, vol.120
, Issue.5 SUPPL. 1
, pp. 4
-
-
Jobson, B.1
Garza, A.2
Sninsky, C.A.3
-
34
-
-
0029134702
-
Azathioprine and 6-mercaptopurine in Crohn's disease: A meta-analysis
-
Pearson D.C., May G.R., Fick G.H., Sutherland L.H. Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Ann Intern Med. 122:1995;132-142
-
(1995)
Ann Intern Med
, vol.122
, pp. 132-142
-
-
Pearson, D.C.1
May, G.R.2
Fick, G.H.3
Sutherland, L.H.4
-
35
-
-
0028899859
-
Methotrexate for the treatment of Crohn's disease
-
Feagan B.G., Rochon J., Fedorak R.N., Irvine E.J., Wild G., Sutherland L., et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med. 332:1995;292-297
-
(1995)
N Engl J Med
, vol.332
, pp. 292-297
-
-
Feagan, B.G.1
Rochon, J.2
Fedorak, R.N.3
Irvine, E.J.4
Wild, G.5
Sutherland, L.6
-
36
-
-
0000189229
-
Medical therapy for Crohn's disease
-
J.B. Kirsner. Philadelphia: WB Saunders
-
Lang K.A., Peppercorn M.A. Medical therapy for Crohn's disease. Kirsner J.B. Inflammatory bowel disease. 5th edition:2000;557-577 WB Saunders, Philadelphia
-
(2000)
Inflammatory Bowel Disease 5th Edition
, pp. 557-577
-
-
Lang, K.A.1
Peppercorn, M.A.2
-
37
-
-
0036897225
-
Infliximab in the treatment of Crohn's disease: A user's guide for clinicians
-
Sandborn W.J., Hanauer S.B. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol. 97:2002;2962-2972
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2962-2972
-
-
Sandborn, W.J.1
Hanauer, S.B.2
-
38
-
-
0029044783
-
Rectal aminosalicylate therapy for distal ulcerative colitis: A meta-analysis
-
Marshall J.K., Irvine E.J. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther. 9:1995;293-300
-
(1995)
Aliment Pharmacol Ther
, vol.9
, pp. 293-300
-
-
Marshall, J.K.1
Irvine, E.J.2
-
39
-
-
0032063660
-
Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: Results of a multicentered placebo-controlled trial
-
Hanauer S.B. Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. Inflamm Bowel Dis. 4:1998;79-83
-
(1998)
Inflamm Bowel Dis
, vol.4
, pp. 79-83
-
-
Hanauer, S.B.1
-
40
-
-
0030827118
-
A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis
-
Safdi M., DeMicco M., Sninsky C., Banks P., Wruble L., Deren J., et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol. 92:1997;1867-1871
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 1867-1871
-
-
Safdi, M.1
Demicco, M.2
Sninsky, C.3
Banks, P.4
Wruble, L.5
Deren, J.6
-
41
-
-
0026693139
-
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis
-
Hawthorne A.B., Logan R.F.A., Hawkey C.J., Foster P.N., Axon A.T.R., Swarbrick E.T., et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ. 305:1992;20-22
-
(1992)
BMJ
, vol.305
, pp. 20-22
-
-
Hawthorne, A.B.1
Logan, R.F.A.2
Hawkey, C.J.3
Foster, P.N.4
Axon, A.T.R.5
Swarbrick, E.T.6
-
42
-
-
0024517127
-
Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease
-
Kozarek R.A., Patterson D.J., Gelfand M.D., Botoman V.A., Ball T.J., Wilske K.R. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 110:1989;353-356
-
(1989)
Ann Intern Med
, vol.110
, pp. 353-356
-
-
Kozarek, R.A.1
Patterson, D.J.2
Gelfand, M.D.3
Botoman, V.A.4
Ball, T.J.5
Wilske, K.R.6
-
43
-
-
9244264980
-
Methotrexate in chronic active ulcerative colitis: A double blind, randomized, Israeli multicenter trial
-
Oren R., Arber N., Odes S., Moshkowitz M., Keter D., Pomeranz I., et al. Methotrexate in chronic active ulcerative colitis: a double blind, randomized, Israeli multicenter trial. Gastroenterology. 110:1996;1416-1421
-
(1996)
Gastroenterology
, vol.110
, pp. 1416-1421
-
-
Oren, R.1
Arber, N.2
Odes, S.3
Moshkowitz, M.4
Keter, D.5
Pomeranz, I.6
-
44
-
-
0001902429
-
A critical review of cyclosporine therapy in inflammatory bowel disease
-
Sandborn W.J. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis. 1:1995;48-63
-
(1995)
Inflamm Bowel Dis
, vol.1
, pp. 48-63
-
-
Sandborn, W.J.1
-
45
-
-
0034892217
-
Infliximab for refractory ulcerative colitis
-
Chey W.Y., Hussain A., Ryan C., Potter G.D., Shah A. Infliximab for refractory ulcerative colitis. Am J Gastroenterol. 96:2001;2373-2381
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2373-2381
-
-
Chey, W.Y.1
Hussain, A.2
Ryan, C.3
Potter, G.D.4
Shah, A.5
-
46
-
-
0036792705
-
Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis
-
Su C., Salzberg B.A., Lewis J.D., Deren J.J., Kornbluth A., Katzka D.A., et al. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol. 97:2002;2577-2584
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2577-2584
-
-
Su, C.1
Salzberg, B.A.2
Lewis, J.D.3
Deren, J.J.4
Kornbluth, A.5
Katzka, D.A.6
-
47
-
-
0034777502
-
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study
-
Sands B.E., Tremaine W.J., Sandborn W.J., Rutgeerts P.J., Hanauer S.B., Mayer L., et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis. 7:2001;83-88
-
(2001)
Inflamm Bowel Dis
, vol.7
, pp. 83-88
-
-
Sands, B.E.1
Tremaine, W.J.2
Sandborn, W.J.3
Rutgeerts, P.J.4
Hanauer, S.B.5
Mayer, L.6
-
48
-
-
0038460945
-
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: A randomized controlled trial
-
[abstract]
-
Probert C.S.J., Hearing S.D., Schreiber S., Kuhbacher T., Ghosh S., Arnott I.D., et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomized controlled trial. [abstract] Gut. 52:2003;998-1002
-
(2003)
Gut
, vol.52
, pp. 998-1002
-
-
Probert, C.S.J.1
Hearing, S.D.2
Schreiber, S.3
Kuhbacher, T.4
Ghosh, S.5
Arnott, I.D.6
-
49
-
-
0036203009
-
Failure to yield: Drug resistance in inflammatory bowel disease
-
Tremaine W.J. Failure to yield: drug resistance in inflammatory bowel disease. Gastroenterology. 122:2002;1165-1167
-
(2002)
Gastroenterology
, vol.122
, pp. 1165-1167
-
-
Tremaine, W.J.1
-
50
-
-
0028267896
-
Frequency of glucocorticoid resistance and dependency in Crohn's disease
-
Munkholm P., Langholz E., Davidsen M., Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 35:1994;360-362
-
(1994)
Gut
, vol.35
, pp. 360-362
-
-
Munkholm, P.1
Langholz, E.2
Davidsen, M.3
Binder, V.4
-
51
-
-
0034903792
-
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
-
Faubion W.A., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 121:2001;255-260
-
(2001)
Gastroenterology
, vol.121
, pp. 255-260
-
-
Faubion, W.A.1
Loftus, E.V.2
Harmsen, W.S.3
Zinsmeister, A.R.4
Sandborn, W.J.5
-
52
-
-
0036088414
-
Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease
-
Gelbmann C.M., Rogler G., Gross V., Gierend M., Bregenzer N., Andus T., et al. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. Am J Gastroenterol. 97:2002;1438-1445
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 1438-1445
-
-
Gelbmann, C.M.1
Rogler, G.2
Gross, V.3
Gierend, M.4
Bregenzer, N.5
Andus, T.6
-
53
-
-
0034058875
-
Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis
-
Honda M., Orii F., Ayabe T., Imai S., Ashida T., Obara T., et al. Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology. 118:2000;859-866
-
(2000)
Gastroenterology
, vol.118
, pp. 859-866
-
-
Honda, M.1
Orii, F.2
Ayabe, T.3
Imai, S.4
Ashida, T.5
Obara, T.6
-
54
-
-
0033959944
-
High multidrug resistance (p-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy
-
Farrell R.J., Murphy A., Long A., Donnelly S., Cherikuri A., O'Toole D., et al. High multidrug resistance (p-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 118:2000;279-288
-
(2000)
Gastroenterology
, vol.118
, pp. 279-288
-
-
Farrell, R.J.1
Murphy, A.2
Long, A.3
Donnelly, S.4
Cherikuri, A.5
O'Toole, D.6
-
55
-
-
0036202803
-
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
-
Dubinsky M.C., Yang H., Hassard P.V., Seidman E.G., Kam L.Y., Abreu M.T., et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology. 122:2002;904-915
-
(2002)
Gastroenterology
, vol.122
, pp. 904-915
-
-
Dubinsky, M.C.1
Yang, H.2
Hassard, P.V.3
Seidman, E.G.4
Kam, L.Y.5
Abreu, M.T.6
-
56
-
-
0034780344
-
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
-
Lowry P.W., Franklin C.L., Weaver A.L., Szumlanski C.L., Mays D.C., Loftus E.V., et al. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut. 49:2001;656-664
-
(2001)
Gut
, vol.49
, pp. 656-664
-
-
Lowry, P.W.1
Franklin, C.L.2
Weaver, A.L.3
Szumlanski, C.L.4
Mays, D.C.5
Loftus, E.V.6
-
57
-
-
0037434552
-
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
-
Baert F., Noman M., Vermeire S., Assche G.V., Haens G.D., Carbonez A., et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med. 348:2003;601-608
-
(2003)
N Engl J Med
, vol.348
, pp. 601-608
-
-
Baert, F.1
Noman, M.2
Vermeire, S.3
Assche, G.V.4
Haens, G.D.5
Carbonez, A.6
-
58
-
-
0037379792
-
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
-
Farrell R.J., Alsahli M., Jeen Y.T., Falchuk K.R., Peppercorn M.A., Michetti P. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology. 124:2003;917-924
-
(2003)
Gastroenterology
, vol.124
, pp. 917-924
-
-
Farrell, R.J.1
Alsahli, M.2
Jeen, Y.T.3
Falchuk, K.R.4
Peppercorn, M.A.5
Michetti, P.6
-
59
-
-
0037379757
-
Preventing antibodies to infliximab in patients with Crohn's disease: Optimize not immunize
-
Sandborn W.J. Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize. Gastroenterology. 124:2003;1140-1145
-
(2003)
Gastroenterology
, vol.124
, pp. 1140-1145
-
-
Sandborn, W.J.1
-
60
-
-
0034798909
-
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis
-
Kane S., Cohen R.D., Aikens J.E., Hanauer S.B. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 96:2001;2929-2933
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2929-2933
-
-
Kane, S.1
Cohen, R.D.2
Aikens, J.E.3
Hanauer, S.B.4
-
61
-
-
0020026256
-
Compliance to therapy in patients on a maintenance dose of sulfasalazine
-
van Hees P.A., van Tongeren J.H. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol. 4:1982;333-336
-
(1982)
J Clin Gastroenterol
, vol.4
, pp. 333-336
-
-
Van Hees, P.A.1
Van Tongeren, J.H.2
-
62
-
-
0037245392
-
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
-
Kane S., Huo D., Aikens J., Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 114:2003;39-43
-
(2003)
Am J Med
, vol.114
, pp. 39-43
-
-
Kane, S.1
Huo, D.2
Aikens, J.3
Hanauer, S.4
-
63
-
-
0035171258
-
Psychiatric predictors of noncompliance in inflammatory bowel disease: Psychiatry and compliance
-
Nigro G., Angelini G., Grosso S.B., Caula G., Sategna-Guidetti C. Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance. J Clin Gastroenterol. 32:2001;66-68
-
(2001)
J Clin Gastroenterol
, vol.32
, pp. 66-68
-
-
Nigro, G.1
Angelini, G.2
Grosso, S.B.3
Caula, G.4
Sategna-Guidetti, C.5
-
64
-
-
0036918044
-
Is your patient taking the medicine? a simple assay to measure compliance with 5-aminosalicylic acid-containing compounds
-
Shaw I.S., Jobson B.A., Silverman D., Ford J., Hearing S.D., Ball D., et al. Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds. Aliment Pharmacol Ther. 16:2002;2053-2059
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 2053-2059
-
-
Shaw, I.S.1
Jobson, B.A.2
Silverman, D.3
Ford, J.4
Hearing, S.D.5
Ball, D.6
-
65
-
-
0035185108
-
Steering azathioprine safely: Lessons from pharmacogenetics
-
Aithal G.P., Hoffmann B.J. Steering azathioprine safely: lessons from pharmacogenetics. Am J Gastroenterol. 96:2001;3202-3203
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 3202-3203
-
-
Aithal, G.P.1
Hoffmann, B.J.2
-
67
-
-
0033922379
-
Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease
-
Goldstein F., DiMarino A.J. Diarrhea as a side effect of mesalamine treatment for inflammatory bowel disease. J Clin Gastroenterol. 31:2000;60-62
-
(2000)
J Clin Gastroenterol
, vol.31
, pp. 60-62
-
-
Goldstein, F.1
Dimarino, A.J.2
-
68
-
-
0023626064
-
Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides
-
Turunen U., Elomaa I., Anttila V.J., Seppala K. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides. Scand J Gastroenterol. 22:1987;798-802
-
(1987)
Scand J Gastroenterol
, vol.22
, pp. 798-802
-
-
Turunen, U.1
Elomaa, I.2
Anttila, V.J.3
Seppala, K.4
-
69
-
-
0028823951
-
Mesalazine induced exacerbation of ulcerative colitis
-
Kapur K.C., Williams G.T., Allison M.C. Mesalazine induced exacerbation of ulcerative colitis. Gut. 37:1995;838-839
-
(1995)
Gut
, vol.37
, pp. 838-839
-
-
Kapur, K.C.1
Williams, G.T.2
Allison, M.C.3
-
71
-
-
0021252279
-
Acute ulcerative colitis-a rare complication of sulfasalazine therapy
-
Ruppin H., Domschke S. Acute ulcerative colitis-a rare complication of sulfasalazine therapy. Hepatogastroenterology. 31:1984;192-193
-
(1984)
Hepatogastroenterology
, vol.31
, pp. 192-193
-
-
Ruppin, H.1
Domschke, S.2
-
72
-
-
0023238082
-
Salicylate induced exacerbation of ulcerative colitis
-
Chakraborty T.K., Bhatia D., Heading R.C., Ford M.J. Salicylate induced exacerbation of ulcerative colitis. Gut. 28:1987;613-615
-
(1987)
Gut
, vol.28
, pp. 613-615
-
-
Chakraborty, T.K.1
Bhatia, D.2
Heading, R.C.3
Ford, M.J.4
-
75
-
-
0022649415
-
Azodisal sodium in the treatment of ulcerative colitis: A study of tolerance and relapse-prevention properties
-
Sandberg-Gertzen J., Jarnerot G., Kraaz W. Azodisal sodium in the treatment of ulcerative colitis: a study of tolerance and relapse-prevention properties. Gastroenterology. 90:1986;1024-1030
-
(1986)
Gastroenterology
, vol.90
, pp. 1024-1030
-
-
Sandberg-Gertzen, J.1
Jarnerot, G.2
Kraaz, W.3
-
76
-
-
0025981890
-
Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects
-
Raimundo A.H., Patil D.H., Frost P.G., Silk D.B.A. Effects of olsalazine and sulphasalazine on jejunal and ileal water and electrolyte absorption in normal human subjects. Gut. 32:1991;270-274
-
(1991)
Gut
, vol.32
, pp. 270-274
-
-
Raimundo, A.H.1
Patil, D.H.2
Frost, P.G.3
Silk, D.B.A.4
-
77
-
-
18144432814
-
Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon
-
Puspok A., Kiener H.P., Oberhuber G. Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum. 43:2000;685-691
-
(2000)
Dis Colon Rectum
, vol.43
, pp. 685-691
-
-
Puspok, A.1
Kiener, H.P.2
Oberhuber, G.3
-
78
-
-
0031468175
-
Acute colitis associated with etodolac
-
Wilcox G., Porensky R.S. Acute colitis associated with etodolac. J Clin Gastroenterol. 25:1997;367-368
-
(1997)
J Clin Gastroenterol
, vol.25
, pp. 367-368
-
-
Wilcox, G.1
Porensky, R.S.2
-
79
-
-
0019476153
-
Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs
-
Rampton D.S., Sladen G.E. Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. Postgrad Med J. 57:1981;297-299
-
(1981)
Postgrad Med J
, vol.57
, pp. 297-299
-
-
Rampton, D.S.1
Sladen, G.E.2
-
80
-
-
0020680648
-
Analgesic ingestion and other factors preceding relapse in ulcerative coltish
-
Rampton D.S., McNeil N.I., Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative coltish. Gut. 24:1983;187-189
-
(1983)
Gut
, vol.24
, pp. 187-189
-
-
Rampton, D.S.1
McNeil, N.I.2
Sarner, M.3
-
81
-
-
0023266579
-
Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease
-
Kaufmann H.J., Taubin H.L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 107:1987;513-516
-
(1987)
Ann Intern Med
, vol.107
, pp. 513-516
-
-
Kaufmann, H.J.1
Taubin, H.L.2
-
82
-
-
0030913612
-
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease
-
Evans J.M.M., McMahon A.D., Murray F.E., McDevitt D.G., MacDonald T.M. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut. 40:1997;619-622
-
(1997)
Gut
, vol.40
, pp. 619-622
-
-
Evans, J.M.M.1
McMahon, A.D.2
Murray, F.E.3
McDevitt, D.G.4
MacDonald, T.M.5
-
83
-
-
0033885778
-
Effects of nonsteroidal anti-inflammatory drugs on inflammatory bowel disease: A case-control study
-
Felder J.B., Korelitz B.I., Rajapakse R., Schwarz S., Horatagis A.P., Gleim G. Effects of nonsteroidal anti-inflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. 95:2000;1949-1954
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 1949-1954
-
-
Felder, J.B.1
Korelitz, B.I.2
Rajapakse, R.3
Schwarz, S.4
Horatagis, A.P.5
Gleim, G.6
-
84
-
-
0030806609
-
Factors influencing the relapse of patients with inflammatory bowel disease
-
Miner P.B. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol. 92:1997;1-4
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 1-4
-
-
Miner, P.B.1
-
85
-
-
0033899563
-
Tolerance of nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease
-
Bonner G.F., Walczak M., Kitchen L., Bayona M. Tolerance of nonsteroidal anti-inflammatory drugs in patients with inflammatory bowel disease. Am J Gastroenterol. 95:2000;1946-1948
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 1946-1948
-
-
Bonner, G.F.1
Walczak, M.2
Kitchen, L.3
Bayona, M.4
-
87
-
-
0033135502
-
Nicotine therapy for ulcerative colitis: A review of rationale, mechanisms, pharmacology, and clinical results
-
Sandborn W.J. Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results. Am J Gastroenterol. 94:1999;1161-1171
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 1161-1171
-
-
Sandborn, W.J.1
-
88
-
-
0029817724
-
Smoking and inflammatory bowel disease
-
Forbes A. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 8:1996;761-763
-
(1996)
Eur J Gastroenterol Hepatol
, vol.8
, pp. 761-763
-
-
Forbes, A.1
-
89
-
-
0026563474
-
Smoking in Crohn's disease: Effect on localisation and clinical course
-
Lindberg E., Jarnerot G., Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut. 33:1992;779-782
-
(1992)
Gut
, vol.33
, pp. 779-782
-
-
Lindberg, E.1
Jarnerot, G.2
Huitfeldt, B.3
-
90
-
-
0025323229
-
Effect of cigarette smoking on recurrence of Crohn's disease
-
Sutherland L.R., Ramcharan S., Bryant H., et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 98:1990;1123-1128
-
(1990)
Gastroenterology
, vol.98
, pp. 1123-1128
-
-
Sutherland, L.R.1
Ramcharan, S.2
Bryant, H.3
-
91
-
-
0030020933
-
Effects of cigarette smoking on the long-term course of Crohn's disease
-
Cosnes J., Carbonnel F., Beaugerie L., Le Quintrec Y., Gendre J.P. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology. 110:1996;424-431
-
(1996)
Gastroenterology
, vol.110
, pp. 424-431
-
-
Cosnes, J.1
Carbonnel, F.2
Beaugerie, L.3
Le Quintrec, Y.4
Gendre, J.P.5
-
92
-
-
0035087887
-
Smoking cessation and the course of Crohn's disease: An intervention study
-
Cosnes J., Beaugerie L., Carbonnel F., Gendre J.P. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 120:2001;1093-1099
-
(2001)
Gastroenterology
, vol.120
, pp. 1093-1099
-
-
Cosnes, J.1
Beaugerie, L.2
Carbonnel, F.3
Gendre, J.P.4
-
93
-
-
0024159566
-
Effects of cigarettes smoking on the clinical course of ulcerative colitis
-
Boyko E.J., Perera D.R., Koepsell T.D., Keane E.M., Inui T.S., et al. Effects of cigarettes smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol. 23:1988;1147-1152
-
(1988)
Scand J Gastroenterol
, vol.23
, pp. 1147-1152
-
-
Boyko, E.J.1
Perera, D.R.2
Koepsell, T.D.3
Keane, E.M.4
Inui, T.S.5
-
94
-
-
0034939476
-
Impact of cessation of smoking on the course of ulcerative colitis
-
Beaugerie L., Massot N., Carbonnel F., Cattan S., Gendre J.P., Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol. 96:2001;2113-2116
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2113-2116
-
-
Beaugerie, L.1
Massot, N.2
Carbonnel, F.3
Cattan, S.4
Gendre, J.P.5
Cosnes, J.6
-
96
-
-
0026044672
-
Transdermal nicotine in active ulcerative colitis
-
Srivastava E.D., Russell M.A.H., Feyerabend C., Williams G.T., Masterson J.G., Rhodes J. Transdermal nicotine in active ulcerative colitis. Eur J Gastroenterol Hepatol. 3:1991;815-818
-
(1991)
Eur J Gastroenterol Hepatol
, vol.3
, pp. 815-818
-
-
Srivastava, E.D.1
Russell, M.A.H.2
Feyerabend, C.3
Williams, G.T.4
Masterson, J.G.5
Rhodes, J.6
-
97
-
-
0028203927
-
Transdermal nicotine for active ulcerative colitis
-
Pullan R.D., Rhodes J., Ganesh S., Mani V., Morris J.S., Williams G.T., et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med. 330:1994;811-815
-
(1994)
N Engl J Med
, vol.330
, pp. 811-815
-
-
Pullan, R.D.1
Rhodes, J.2
Ganesh, S.3
Mani, V.4
Morris, J.S.5
Williams, G.T.6
-
98
-
-
0028969795
-
Transdermal nicotine as maintenance therapy for ulcerative colitis
-
Thomas G.A.O., Rhodes J., Mani V., Williams G.T., Newcombe R.G., Russell M.A.H., et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med. 332:1995;988-992
-
(1995)
N Engl J Med
, vol.332
, pp. 988-992
-
-
Thomas, G.A.O.1
Rhodes, J.2
Mani, V.3
Williams, G.T.4
Newcombe, R.G.5
Russell, M.A.H.6
-
99
-
-
0029835749
-
Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis
-
Thomas G.A.O., Rhodes J., Ragunath K., Mani V., Williams G.T., Newcombe R.G., et al. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Eur J Gastroenterol Hepatol. 8:1996;769-776
-
(1996)
Eur J Gastroenterol Hepatol
, vol.8
, pp. 769-776
-
-
Thomas, G.A.O.1
Rhodes, J.2
Ragunath, K.3
Mani, V.4
Williams, G.T.5
Newcombe, R.G.6
-
100
-
-
15644374610
-
Transdermal nicotine for mildly to moderately active ulcerative colitis: A randomized, double-blind, placebo-controlled trial
-
Sandborn W.J., Tremaine W.J., Offord K.P., Lawson G.M., Petersen B.T., Batts K.P., et al. Transdermal nicotine for mildly to moderately active ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 126:1997;364-371
-
(1997)
Ann Intern Med
, vol.126
, pp. 364-371
-
-
Sandborn, W.J.1
Tremaine, W.J.2
Offord, K.P.3
Lawson, G.M.4
Petersen, B.T.5
Batts, K.P.6
-
101
-
-
0032865549
-
Nicotine treatment for ulcerative colitis
-
Guslandi M. Nicotine treatment for ulcerative colitis. Br J Clin Pharmacol. 48:1999;481-484
-
(1999)
Br J Clin Pharmacol
, vol.48
, pp. 481-484
-
-
Guslandi, M.1
|